Clean Science & Technology Ltd logo

Clean Science & Technology Ltd

CLEAN NSE

Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]

AI Verdict: HOLD Confidence: 4%

Clean Science trades at a PE of 36.7x despite a -13% TTM profit decline and -1% TTM sales growth, suggesting the premium valuation is not supported by current fundamentals. The debt-free balance sheet and strong 5-year ROE of 23% provide a margin of safety, but the stock's -47% one-year CAGR and deteriorating working capital cycle warrant caution before fresh entry.

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹8,408 Cr
Volatility
Moderate
P/E Ratio
36.05
EBITDA
₹355 Cr
Return on Equity
20.28%
Debt to Equity
0
Book Value
₹149.01
EPS
₹23.62
52W High
₹1,521.9
52W Low
₹652

Technical Indicators

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 21.5%

Weaknesses

2
  • Promoter holding has decreased over last 3 years: -27.2%
  • Working capital days have increased from 144 days to 242 days

Growth Rate

Revenue Growth
-4.84% ↘
Net Income Growth
-16.30% ↘
Cash Flow Change
-9.56% ↘
ROE
-7.94% ↘
ROCE
-7.03% ↘
EBITDA Margin (Avg.)
-15.33% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 20d ago
HOLD
Risk high

Clean Science trades at a PE of 36.7x despite a -13% TTM profit decline and -1% TTM sales growth, suggesting the premium valuation is not supported by current fundamentals. The debt-free balance sheet and strong 5-year ROE of 23% provide a margin of safety, but the stock's -47% one-year CAGR and deteriorating working capital cycle warrant caution before fresh entry.

Bull Case 7
  • Company is virtually debt-free, providing significant financial flexibility and resilience during downturns with a near-zero debt-to-equity ratio
  • 5-year average ROE of 23% demonstrates strong capital efficiency and a historically high-quality business model
  • 64.29% of analysts (9 out of 14) have a Buy rating, reflecting consensus confidence in long-term recovery potential
  • 5-year compounded sales CAGR of 13% shows the business has a credible track record of top-line growth over a longer horizon
  • Healthy dividend payout ratio of 21.5% with a current yield of 0.25% signals management commitment to returning capital to shareholders
  • Market cap of Rs 8,537 Cr positions it as a mid-cap specialty chemical player with potential re-rating if growth resumes
  • Price-to-book of 5.33x, while elevated, is lower than peak multiples historically enjoyed by specialty chemical peers, indicating partial correction has already occurred
Bear Case 8
  • Stock price has declined -47% over the past 1 year, indicating severe loss of market confidence and broken momentum
  • TTM compounded profit growth is -13%, showing earnings are actively contracting rather than just stagnating
  • 3-year compounded profit CAGR of -8% confirms this is not a one-quarter blip but a sustained earnings deterioration
  • Working capital days have ballooned from 144 days to 242 days — a 68% increase — signaling potential demand slowdown or inventory pile-up
  • Promoter holding has decreased by 27.2% over 3 years, a significant red flag suggesting insider confidence may be waning
  • PE of 36.7x remains expensive for a company delivering negative profit growth, creating further downside risk if de-rating continues
  • TTM sales growth of -1% and 3-year sales CAGR of just 1% indicate the top-line engine has stalled
  • Last year ROE dropped to 15% from a 3-year average of 19% and 5-year average of 23%, showing declining return quality

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 20d ago
Positives 2
  • 5,000 ESOPs granted at ₹500 May 14

    NRC approved 5,000 stock options at ₹500/option on May 14, 2026 under ESOP Scheme 2021 with a four-year vesting schedule, signaling employee retention focus.

  • Solid FY26 profitability maintained May 14

    Standalone revenue of ₹8,153.35 million and net profit of ₹2,512.17 million for FY26, with a final dividend of ₹4 per share recommended.

Neutral 2
  • Promoter transfers 9.5% stake via gift Jun 1

    AAB Business Trust will receive 1.01 crore shares from Mrs. Asha Ashok Boob via gift, scheduled on or after June 6, 2026. Intra-promoter group transfer with no change in overall promoter holding.

  • FY26 results declared with dividend May 14

    Clean Science reported FY26 standalone revenue of ₹8,153.35 million and net profit of ₹2,512.17 million, recommending ₹4/share final dividend.

TL;DR: Clean Science posted steady FY26 numbers with ₹2,512 million net profit and maintained shareholder returns via a ₹4 dividend. No visible headwinds emerged in recent news flow. The intra-promoter stake transfer is structural and does not alter control dynamics. Outlook remains stable with employee incentive alignment via ESOPs, though growth catalysts or capacity expansion updates are awaited for re-rating potential.

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
217
188
181
195
228
224
238
241
264
243
245
220
249
Expenses
112
112
106
108
133
129
148
142
159
143
158
147
153
Operating Profit
105
76
75
87
95
95
90
98
105
100
87
72
96
OPM %
48%
40%
41%
44%
42%
42%
38%
41%
40%
41%
36%
33%
38%
Other Income
13
13
6
8
14
10
11
5
12
13
7
10
3
Interest
0
0
0
0
1
0
0
0
0
0
0
0
0
Depreciation
10
11
11
11
13
16
18
18
17
19
19
19
21
PBT
108
79
69
83
95
89
83
85
100
95
75
63
78
Tax %
25%
25%
25%
25%
26%
26%
29%
23%
26%
26%
26%
27%
25%
Net Profit
81
59
52
63
70
66
59
66
74
70
55
46
58
EPS in Rs
7.58
5.55
4.91
5.89
6.61
6.2
5.53
6.18
6.97
6.59
5.22
4.32
5.48
Figures in ₹ Crores

Profit & Loss

  Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
241
393
419
512
685
936
791
967
957
Expenses
167
257
234
253
385
533
459
579
602
Operating Profit
74
137
186
260
300
403
332
388
355
OPM %
31%
35%
44%
51%
44%
43%
42%
40%
37%
Other Income
5
11
11
25
30
30
41
39
33
Interest
1
0
0
0
0
1
1
1
0
Depreciation
8
11
14
17
25
36
46
69
78
PBT
70
137
182
267
305
396
326
357
310
Tax %
30%
28%
23%
26%
25%
25%
25%
26%
26%
Net Profit
49
98
140
198
228
295
244
264
230
EPS in Rs
345
690
1,052
18.68
21.51
27.78
22.97
24.88
21.61
Div. Payout %
12%
15%
2%
134%
15%
18%
22%
24%
19%
Figures in ₹ Crores

Balance Sheet

  Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
11
11
11
11
11
11
Reserves
186
271
341
529
758
999
1,193
1,406
1,573
Borrowings
1
3
3
0
0
2
2
2
2
Other Liabilities
48
53
85
120
156
140
191
181
197
Total Liabilities
236
327
430
660
925
1,152
1,396
1,600
1,783
Fixed Assets
102
127
166
186
296
460
636
715
760
CWIP
2
4
3
55
44
20
57
30
118
Investments
18
75
133
232
191
353
339
381
405
Other Assets
114
121
128
187
394
318
364
474
500
Total Assets
236
327
430
660
925
1,152
1,396
1,600
1,783
Figures in ₹ Crores

Cash Flow

  Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
45
85
160
193
127
279
236
214
275
Investing
-17
-94
-105
-187
-79
-270
-185
-152
-203
Financing
-5
-11
-55
-6
0
-55
-53
-53
-64
Net Cash Flow
23
-20
0
0
49
-45
-2
10
8
Free Cash Flow
13
46
110
109
-12
96
10
72
74
CFO/OP
91
88
109
100
65
93
94
80
103
Figures in ₹ Crores

Ratios

  Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
60
55
61
53
82
57
76
77
79
Inventory Days
93
79
98
156
143
122
163
156
157
Days Payable
85
48
101
180
166
90
139
103
118
Cash Conversion Cycle
69
87
58
29
59
89
99
129
118
Working Capital Days
60
62
33
32
90
68
86
105
242
ROCE %
—
59%
59%
61%
47%
44%
29%
27%
21%

Shareholding Pattern

As of Mar 2026
Promoters 51.29%
DIIs 17.14%
FIIs 13.39%
Public 11.24%
Others 6.92%
Government 0.01%
Total 99.99%
  Apr 2021Jun 2021Jul 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
94.65%
94.65%
78.51%
78.51%
78.51%
78.51%
78.51%
78.50%
78.50%
78.50%
74.99%
74.98%
74.98%
74.98%
74.98%
74.97%
74.97%
74.97%
74.97%
50.97%
50.96%
51.29%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
6.00%
0.00%
5.88%
6.06%
5.83%
5.98%
6.07%
6.21%
11.14%
10.00%
13.39%
DIIs
0.00%
0.37%
3.69%
4.29%
3.82%
3.59%
4.37%
4.45%
4.64%
4.76%
6.41%
5.23%
5.03%
5.04%
4.55%
4.77%
5.46%
5.76%
5.92%
18.98%
19.76%
17.14%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.01%
0.01%
Public
0.00%
0.44%
8.09%
6.90%
6.40%
6.74%
6.86%
6.99%
7.01%
6.92%
6.96%
7.86%
8.02%
8.20%
8.40%
8.29%
8.08%
7.78%
7.59%
11.73%
12.45%
11.24%
Others
5.35%
4.53%
9.71%
10.30%
11.26%
11.17%
10.26%
10.06%
9.85%
9.82%
11.65%
5.93%
11.97%
5.91%
6.01%
6.14%
5.51%
5.42%
5.31%
7.19%
6.81%
6.92%
No. of Shareholders
0
26
31
3,79,361
2,44,336
2,42,642
2,63,593
2,70,446
2,70,616
2,70,823
2,66,971
2,85,259
2,78,653
2,79,395
2,73,841
2,54,629
2,46,798
2,37,016
2,25,484
2,39,974
2,43,606
2,37,113

Documents

Frequently Asked Questions about Clean Science & Technology Ltd

What does Clean Science & Technology Ltd do?
Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and...
Where is Clean Science & Technology Ltd (CLEAN) listed?
Clean Science & Technology Ltd is listed on the Indian stock exchanges. It is listed on NSE: CLEAN and BSE: 543318. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Clean Science & Technology Ltd belong to?
Clean Science & Technology Ltd operates in the Commodities sector within the Chemicals & Petrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Clean Science & Technology Ltd?
Clean Science & Technology Ltd has a market capitalisation of approximately ₹8408.07 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Clean Science & Technology Ltd?
The Price-to-Earnings (PE) ratio of Clean Science & Technology Ltd is 36.05. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Clean Science & Technology Ltd?
Over the past 52 weeks, Clean Science & Technology Ltd has traded between a low of ₹652 and a high of ₹1,521.9. This range helps investors understand the stock's price volatility and recent trading levels.
Does Clean Science & Technology Ltd pay dividends?
Yes, Clean Science & Technology Ltd has a dividend yield of 0.25%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Clean Science & Technology Ltd?
Clean Science & Technology Ltd has a Return on Equity (ROE) of 20.28%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Clean Science & Technology Ltd on Tapetide?
On Tapetide, you can view Clean Science & Technology Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]

Website cleanscience.co.in
CEO Mr. Ashok Ramnarayan Boob
Employees 458
Listed 2021-07-19
Face Value ₹ 1
Issued Size 10,62,76,499

Explore More

More in Commodities → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List